Related Experiment Videos
Increased granzyme B mRNA after alloincompatible myoblast transplantation
B Guérette1, R Roy, M Tremblay
1Centre de Recherche en Neurobiologie, Hôpital de l'Enfant-Jésus, Université Laval, Ste-Foy, Quebec, Canada.
Transplantation
|November 15, 1995
Summary
Myoblast transplantation into mice revealed that immune cells infiltrate and activate in response to foreign tissues. Dystrophin alone did not trigger a significant immune response, suggesting immunosuppression is crucial for histoincompatible grafts.
Area of Science:
- Immunology
- Cell Biology
- Transplantation Science
Background:
- Myoblast transplantation is a potential therapy for muscular dystrophies.
- Investigating immune responses to myoblast transplants is crucial for clinical success.
- Previous studies noted immune cell infiltration after myoblast transplantation.
Purpose of the Study:
- To assess lymphocyte activation following myoblast transplantation.
- To evaluate the immune response against MHC and dystrophin.
- To determine the immunogenicity of dystrophin in mdx mice.
Main Methods:
- Myoblast transplantation into tibialis anterior muscles of C57BL/10SnJ, C57BL/ScSn mdx, and BALB/c mice.
- Detection of granzyme B mRNA using reverse-transcriptase polymerase chain reaction (RT-PCR).
- Standardization of results using beta-actin mRNA amplification.
Main Results:
- Granzyme B mRNA expression increased for at least 3 weeks post-MHC alloincompatible transplantation.
- No significant increase in granzyme B expression was observed after allocompatible transplantation in mdx mice.
- These findings suggest dystrophin is not highly immunogenic in the short term.
Conclusions:
- Infiltrating lymphocytes in histoincompatible myoblast transplants are activated.
- The study highlights the need for immunosuppression in myoblast transplantation involving MHC incompatibility.
- Dystrophin's limited short-term immunogenicity suggests potential for therapeutic application without immediate rejection concerns.